Mitral valve disease is one of the most common heart valve problems, and tricuspid valve disease is a growing concern. Stanford Medicine has several clinical trials exploring new minimally invasive valve treatments.

There are a variety of transcatheter valve therapies, which are safer than open-heart surgery for patients. For example, MitraClip™ is a small device doctors can place on the mitral valve to reduce leakage. For patients with heart failure, MitraClip is more effective than surgery.

Hear Dr. Rahul Sharma explain more about transcatheter valve procedures and the benefits they provide.

View more videos about interventional cardiology treatments »

Learn more:

Mitral Valve Stenosis and Regurgitation
https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/mitral-valve-stenosis-regurgitation.html

Transcatheter Mitral Valve Repair (TMVR)
https://stanfordhealthcare.org/medical-treatments/t/transcatheter-mitral-valve-repair.html

Structural Heart Program
https://stanfordhealthcare.org/medical-clinics/structural-heart-program.html

Rahul Sharma, MBBS, FRACP
Interventional cardiologist, Director of Structural Interventions